Top Markets
#1 Glidr Glidr +51.75%
#2 Akedo Akedo +50.60%
#3 DOVU DOVU +47.96%
#4 Velvet Velvet +40.81%
#5 Black Phoenix Black Phoenix +34.22%
#6 Cross Cross +24.07%
#7 Cysic Cysic +18.58%
#8 Perle Perle +18.11%
#9 Bitway Bitway +15.43%
#10 QANplatform QANplatform +15.10%
Coin of the day
Glidr Glidr
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Chimeric Therapeutics Limited Chimeric Therapeutics Limited

Chimeric Therapeutics Limited

CHM
Rang in Aktien #38382
Chimeric Therapeutics Ltd. is an Australian clinical-stage biopharmaceutical... Chimeric Therapeutics Ltd. is an Australian clinical-stage biopharmaceutical firm dedicated to developing and commercializing a diverse array of cell therapies designed to combat various cancers. Its lead natural killer (NK) cell platform, CHM 0201, is currently undergoing Phase I clinical evaluation for both solid tumors and hematological malignancies. Another key candidate, CHM 1101 (a CLTX CAR T therapy), is also in Phase I trials, specifically targeting recurrent or progressive glioblastoma in patients expressing MMP2+. Beyond these, the company's development pipeline encompasses CHM 0301 for blood cancers; CLTX CAR NK (CHM 1301) and CDH17 CAR NK (CHM 2301) for solid tumors. The CLTX CAR T platform (CHM 1101) is additionally being investigated for melanoma, colorectal, and prostate cancers, while CDH17 CAR T (CHM 2101) is being developed for neuroendocrine, colorectal, pancreatic, and gastric cancers. Chimeric Therapeutics, headquartered in Carlton, Australia, was founded in 2020.
Aktienkurs
$0.02468497
Marktkapitalisierung
$1.01M
Veränderung (1 Tag)
-12.50%
Veränderung (1 Jahr)
-87.34%
Land
AU
Handel Chimeric Therapeutics Limited (CHM)

Kategorie

Healthcare
Preis CHM mit Marktkapitalisierung von B
Chimeric Therapeutics Limited Chimeric Therapeutics Limited
CHM
$0.02468497
Marktkapitalisierung von Chimeric Therapeutics Limited(CHM)
Marktkapitalisierung: $1.01M
Mit Stand August 2026 hat Chimeric Therapeutics Limited eine Marktkapitalisierung von $1.01M. Das macht Chimeric Therapeutics Limited laut unseren Daten zum 38382nd wertvollsten Unternehmen der Welt nach Marktkapitalisierung. Die Marktkapitalisierung ist der Gesamtmarktwert aller ausstehenden Aktien eines börsennotierten Unternehmens und wird häufig verwendet, um den Unternehmenswert zu bestimmen.
Marktkapitalisierung von Chimeric Therapeutics Limited von 2021 bis 2026
CHM im Vergleich zu den Top 5 der beliebtesten stocks
Preis für CHM Vermögenswert B Marktkapitalisierung von B Ergebnisse
Chimeric Therapeutics Limited Chimeric Therapeutics Limited
$132,828 $1.01M
NVIDIA Corporation NVIDIA Corporation
NVDA
$5.452T +538,091,748.10%
Chimeric Therapeutics Limited Chimeric Therapeutics Limited
$109,440 $1.01M
Apple Inc. Apple Inc.
AAPL
$4.492T +443,347,174.13%
Chimeric Therapeutics Limited Chimeric Therapeutics Limited
$101,475 $1.01M
Alphabet Inc. Alphabet Inc.
GOOG
$4.165T +411,081,281.86%
Chimeric Therapeutics Limited Chimeric Therapeutics Limited
$89,569.39 $1.01M
Microsoft Corporation Microsoft Corporation
MSFT
$3.676T +362,849,843.20%
Chimeric Therapeutics Limited Chimeric Therapeutics Limited
$69,023.47 $1.01M
Amazon.com, Inc. Amazon.com, Inc.
AMZN
$2.833T +279,617,311.27%